Patents
Patents for C07C 335 - Thioureas, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (3,175)
01/2004
01/15/2004US20040010036 Solid phase synthesis
01/15/2004US20040009982 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
01/14/2004EP1379517A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis
01/14/2004EP1379495A2 Ligands of the alpha-v-beta 6 integrin
01/14/2004CN1468227A Non-imidazole aryloxyalkylamines
01/14/2004CN1468221A Non-imidazole aryloxypiperidines
01/14/2004CN1468214A Novel derivatives of aminocyclohexane
01/07/2004EP1377290A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
01/07/2004EP1377283A2 Compounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
01/02/2004EP0836595B1 Triazoline and isoxazoline bis-oxime derivatives and their use as pesticides
01/01/2004US20040002478 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
12/2003
12/25/2003US20030236287 Central nervous system disorders; analgesics; antiinflammatory agents; cognition activators; anticancer agents; antidiabetic agents
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/18/2003WO2003103651A1 Compounds of the formu;a r1-x-y-z-nr2r3 as abca-1 elevating agents against cad or atherosclerosis
12/18/2003WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1100775B1 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
12/10/2003EP1368309A2 Thiol-modified hyaluronan
12/09/2003US6660879 Use of the compound in clinical conditions associated with insulin resistance.
12/04/2003WO2003057169A3 4-dedimethylamino tetracycline compounds
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/03/2003EP1366440A2 Method of operating a computer system to perform a discrete substructural analysis
12/02/2003US6657082 Process for the preparation of thiourea
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
11/2003
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/26/2003EP1363875A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
11/25/2003US6653505 Oxidation resistance
11/20/2003WO2003095396A2 N,n,-substituted s-aryl-isothioureas, n,n,n'-substituted s-aryl-isothioureas and combinatorial libraries thereof
11/13/2003WO2003093250A2 Positive allosteric modulators of the nicotinic acetylcholine receptor
11/13/2003WO2003093224A1 Amidinylphenyl compounds and their use as fungicides
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212116 Contorlling plant disease
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/11/2003US6645968 Potassium channel openers
11/05/2003EP1357908A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
10/2003
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030204113 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same
10/30/2003US20030203944 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
10/29/2003CN1451653A Process for environmentally friendly preparing thioureido propionic acid
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1183236B1 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
10/22/2003CN1125045C Process for producing intermecliates used in process for producing-2-iminothiazoline derivatives
10/15/2003CN1448387A Process for producing thiourea dioxide
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/07/2003US6630600 Intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
10/02/2003WO2002033596A3 Method of operating a computer system to perform a discrete substructural analysis
10/01/2003EP1084102B1 New 3-aryl propionic acid derivatives and analogs
10/01/2003CN1122442C Fungicidal mixtures
09/2003
09/25/2003WO2003078390A1 Phenolic compound and recording material containing the same
09/24/2003EP1345892A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives
09/24/2003EP0923543B1 Potassium channel inhibitors
09/24/2003CN1444572A 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/17/2003CN1443179A Aniline derivatives
09/17/2003CN1442406A Method of producing thiourea using acidic waste gas discharged from oil refinery
09/17/2003CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
09/16/2003US6620927 Biscarbodiimides, bisthiourea derivatives, bisurea derivatives having a disulfide bond; crosslinking hyaluronic acids and dervivatives to form high viscosity sustained release, drug delivery agents; eye surgery; tissue engineering
09/12/2003WO2003074495A1 Hppars activators
09/12/2003WO2003074467A2 Urea derivatives as hiv aspartyl protease inhibitors
09/11/2003US20030171351 2'-substituted 1,1'-biphenyl-2-carboxamides, process for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/04/2003WO2002070468A3 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
09/04/2003US20030166798 Mixtures of condensation polymers comprising organonitrogen or organosulfur polymers and curing agents, having preferential binding, used for analysis, separation and resolution of racemic mixtures
09/04/2003US20030166740 Composition containing a polymerizable reducing agent, kit, and method
09/03/2003EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/03/2003EP0977741B1 Substituted phenyl derivatives, their preparation and use
09/03/2003CN1440383A PPARγ调制剂 PPARγ modulators
08/2003
08/21/2003US20030158442 Process for the production of nitrogen compounds
08/21/2003US20030158226 Treating or preventing emphysema, cancer and dermatological disorders
08/20/2003CN1437580A 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
08/20/2003CN1118462C Substituted phenyl derivatives, producing method and use thereof
08/14/2003WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto
08/14/2003US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same
08/07/2003US20030149083 For therapy of inflammatory diseases, rheumatoid arthritis, inflammatory bowel diseases, systemic erythematodes, multiple sclerosis, Sjogren's syndrome, asthma, psoriasis, allergy, diabetes, cardiovascular diseases, arterial sclerosis
08/06/2003EP1084103B1 New 3-aryl-2-hydroxypropionic acid derivative (i)
08/06/2003CN1116871C Pharmaceutical compositions and containing S-alkylisothiouronium derivatives
07/2003
07/31/2003WO2002062762A3 Potassium channel openers
07/29/2003US6600063 Novel antimycobacterial compounds and in particular to antimycobacterial compounds comprised of derivatives of phenyl 4-aminosalicylate. This invention further relates to methods for their preparation, to form drugs
07/24/2003WO2003046200A3 Methods for ligand discovery
07/24/2003US20030139470 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
07/23/2003EP0984688B1 Fungicidal mixtures
07/17/2003WO2003057792A2 Composition containing a polymerizable reducing agent, kit, and method
07/17/2003WO2003057169A2 4-dedimethylamino tetracycline compounds
07/17/2003US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor
07/17/2003US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus
07/16/2003CN1430600A 7-and 9-carbamate, urea, thiourea, thiocarbamate and heteroaryl-amino substituted tetracycline compounds
07/15/2003US6593466 Guanidinium functionalized nucleotides and precursors thereof
07/09/2003EP1324986A1 Nitrogen-containing compounds and their use as glycine transport inhibitors
07/09/2003EP1324979A2 Ionic liquids and their use as solvents
07/03/2003US20030125383 For treating or preventing emphysema, cancer and dermatological disorders
07/03/2003US20030125348 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide
07/01/2003US6586628 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same
06/2003
06/26/2003US20030119902 Novel aminobenzoephenones
06/26/2003US20030119876 Compounds for the treatment of protozoal diseases
06/26/2003US20030118877 New electrode materials derived from polyquinonic ionic compounds and their use in electrochemical generators
06/19/2003US20030114532 Contacting human or nonhuman animal skin or hair with a compound containing 1-(3-methoxybenzyl)-3-substituted thiourea for for inhibiting free radical degradation
06/12/2003US20030109459 Activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms and/or damage are related to the binding of VCAM-1 to cells expressing VLA-4.
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 32